Literature DB >> 16225828

MeCP2 dysfunction in humans and mice.

Huda Y Zoghbi1.   

Abstract

Rett syndrome is a leading cause of postnatal neurodevelopmental regression. Rett syndrome is caused by mutations in MECP2, the gene encoding methyl-CpG binding protein 2. In up to 96% of all classic cases, Rett syndrome cases are caused by mutations or deletions in MECP2. The phenotypic spectrum of MECP2 mutations is broad and includes mental retardation with or without seizures, Angelman syndrome-like phenotype, and autism. Mecp308/Y mice carry a truncating mutation and display many of the features seen in Rett syndrome. Social behavior abnormalities and impaired social interactions in Mecp308/Y mice suggest that MeCP2 plays a role in modulating the activity of genes and neurons important for social interactions. Mice that overexpress MeCP2 at twice the endogenous levels develop a progressive neurologic disorder, demonstrating that MeCP2 levels are tightly regulated and raising the possibility that duplications or gain-of-function mutations of MECP2 might underlie some cases of neurodevelopmental X-linked disorders.

Entities:  

Mesh:

Year:  2005        PMID: 16225828     DOI: 10.1177/08830738050200090701

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  33 in total

1.  A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing.

Authors:  Steven W Long; Jenny Y Y Ooi; Peter M Yau; Peter L Jones
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation.

Authors:  Malaika K Singleton; Michael L Gonzales; Karen N Leung; Dag H Yasui; Diane I Schroeder; Keith Dunaway; Janine M LaSalle
Journal:  Neurobiol Dis       Date:  2011-03-21       Impact factor: 5.996

3.  Profile of Huda Y. Zoghbi.

Authors:  Regina Nuzzo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 4.  Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Authors:  Lisa M Monteggia; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

5.  A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.

Authors:  Alexander H Joyner; Cooper Roddey J; Cinnamon S Bloss; Trygve E Bakken; Lars M Rimol; Ingrid Melle; Ingrid Agartz; Srdjan Djurovic; Eric J Topol; Nicholas J Schork; Ole A Andreassen; Anders M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 6.  Regression in autistic spectrum disorders.

Authors:  Gerry A Stefanatos
Journal:  Neuropsychol Rev       Date:  2008-10-28       Impact factor: 7.444

Review 7.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

Review 8.  The role of MeCP2 in brain development and neurodevelopmental disorders.

Authors:  Michael L Gonzales; Janine M LaSalle
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

9.  Synaptic maturation at cortical projections to the lateral amygdala in a mouse model of Rett syndrome.

Authors:  Frédéric Gambino; Malik Khelfaoui; Bernard Poulain; Thierry Bienvenu; Jamel Chelly; Yann Humeau
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Gene clusters, molecular evolution and disease: a speculation.

Authors:  Leah I Elizondo; Paymaan Jafar-Nejad; J Marietta Clewing; Cornelius F Boerkoel
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.